Defective glucose and lipid metabolism in rheumatoid arthritis is determined by chronic inflammation in metabolic tissues

Rheumatoid arthritis (RA) patients are at increased risk of insulin resistance (IR); however, the specific mechanisms mediating this association are currently unknown.

[1]  Mee-Sup Yoon.  The Role of Mammalian Target of Rapamycin (mTOR) in Insulin Signaling , 2017, Nutrients.

[2]  O. Vittecoq,et al.  Rheumatoid arthritis, insulin resistance, and diabetes. , 2017, Joint, bone, spine : revue du rhumatisme.

[3]  A. Toker,et al.  AKT/PKB Signaling: Navigating the Network , 2017, Cell.

[4]  D. Langin,et al.  Adipocyte lipolysis and insulin resistance. , 2016, Biochimie.

[5]  M. Budoff,et al.  Insulin Resistance in Rheumatoid Arthritis: Disease‐Related Indicators and Associations With the Presence and Progression of Subclinical Atherosclerosis , 2015, Arthritis & rheumatology.

[6]  Ryan A. Kellogg,et al.  Noise Facilitates Transcriptional Control under Dynamic Inputs , 2015, Cell.

[7]  Y. Bustanji,et al.  Adiponectin serum levels correlate with insulin resistance in type 2 diabetic patients , 2014, Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society.

[8]  B. Lu,et al.  Effect of Hydroxychloroquine on Insulin Sensitivity and Lipid Parameters in Rheumatoid Arthritis Patients Without Diabetes Mellitus: A Randomized, Blinded Crossover Trial , 2014, Arthritis care & research.

[9]  M. González-Gay,et al.  Inflammation and Lipid Profile in Rheumatoid Arthritis: Bridging an Apparent Paradox Editorial , 2022 .

[10]  F. Villarroya,et al.  Alarmin high-mobility group B1 (HMGB1) is regulated in human adipocytes in insulin resistance and influences insulin secretion in β-cells , 2014, International Journal of Obesity.

[11]  K. Mahajan,et al.  PI3K‐independent AKT activation in cancers: A treasure trove for novel therapeutics , 2012, Journal of cellular physiology.

[12]  J. Suttles,et al.  Mammalian Target of Rapamycin Complex 2 (mTORC2) Negatively Regulates Toll-like Receptor 4-mediated Inflammatory Response via FoxO1* , 2011, The Journal of Biological Chemistry.

[13]  A. Silman,et al.  UvA-DARE (Digital Academic Repository) 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative Aletaha, , 2010 .

[14]  A. Silman,et al.  Rheumatoid arthritis classifi cation criteria : an American College of Rheumatology / European League Against Rheumatism collaborative initiative , 2010 .

[15]  M. Houssen,et al.  Insulin resistance in early untreated rheumatoid arthritis patients. , 2010, Clinical biochemistry.

[16]  A. Vidal-Puig,et al.  Adipose tissue expandability, lipotoxicity and the Metabolic Syndrome--an allostatic perspective. , 2010, Biochimica et biophysica acta.

[17]  L. Platanias,et al.  Growth suppressive cytokines and the AKT/mTOR pathway. , 2009, Cytokine.

[18]  M. Nurmohamed.  Cardiovascular risk in rheumatoid arthritis. , 2009, Autoimmunity reviews.

[19]  Mohsen Sadatsafavi,et al.  Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies. , 2008, Arthritis and rheumatism.

[20]  T. Pincus,et al.  Prevalence of the metabolic syndrome is increased in rheumatoid arthritis and is associated with coronary atherosclerosis. , 2008, Atherosclerosis.

[21]  G. Paolisso,et al.  Insulin resistance is an independent risk factor for atherosclerosis in rheumatoid arthritis , 2007, Diabetes & vascular disease research.

[22]  P. Arner,et al.  NF-kappaB is important for TNF-alpha-induced lipolysis in human adipocytes. , 2007, Journal of lipid research.

[23]  Laxman Yetukuri,et al.  PPAR gamma 2 Prevents Lipotoxicity by Controlling Adipose Tissue Expandability and Peripheral Lipid Metabolism , 2007, PLoS genetics.

[24]  M. Netea,et al.  The role of TNF-alpha in chronic inflammatory conditions, intermediary metabolism, and cardiovascular risk. , 2007, Journal of lipid research.

[25]  B. Joffe,et al.  Insulin resistance and impaired beta cell function in rheumatoid arthritis. , 2006, Arthritis and rheumatism.

[26]  J. Papadakis,et al.  Metabolic syndrome is common among middle-to-older aged Mediterranean patients with rheumatoid arthritis and correlates with disease activity: a retrospective, cross-sectional, controlled, study , 2006, Annals of the rheumatic diseases.

[27]  C. Kahn,et al.  Critical nodes in signalling pathways: insights into insulin action , 2006, Nature Reviews Molecular Cell Biology.

[28]  M Cutolo,et al.  Safety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial data , 2005, Annals of the rheumatic diseases.

[29]  H. Hauner.  Secretory factors from human adipose tissue and their functional role , 2005, Proceedings of the Nutrition Society.

[30]  R. Tian.  Another role for the celebrity: Akt and insulin resistance. , 2005, Circulation research.

[31]  RongTian.  Another Role for the Celebrity , 2005 .

[32]  M. Pfaffl,et al.  Determination of stable housekeeping genes, differentially regulated target genes and sample integrity: BestKeeper – Excel-based tool using pair-wise correlations , 2004, Biotechnology Letters.

[33]  U. Smith.  Impaired (‘diabetic’) insulin signaling and action occur in fat cells long before glucose intolerance—is insulin resistance initiated in the adipose tissue? , 2002, International Journal of Obesity.

[34]  C. Kahn,et al.  Targeted disruption of the glucose transporter 4 selectively in muscle causes insulin resistance and glucose intolerance , 2000, Nature Medicine.

[35]  G. Shulman,et al.  Disruption of IRS-2 causes type 2 diabetes in mice , 1998, Nature.

[36]  E. Skolnik,et al.  Inhibition of insulin receptor signaling by TNF: potential role in obesity and non-insulin-dependent diabetes mellitus. , 1996, Cytokine & growth factor reviews.

[37]  S. Klein,et al.  Relationship Between Insulin Sensitivity and Plasma Leptin Concentration in Lean and Obese Men , 1996, Diabetes.

[38]  G. Dagenais,et al.  Hyperinsulinemia as an independent risk factor for ischemic heart disease. , 1996, The New England journal of medicine.

[39]  C. Kahn,et al.  Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene , 1994, Nature.

[40]  M. Liang,et al.  The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. , 1988, Arthritis and rheumatism.

[41]  M. Cassader,et al.  Deflazacort vs Prednisone: Effect on Blood Glucose Control in Insulin-Treated Diabetics , 1987 .

[42]  R. Turner,et al.  Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man , 1985, Diabetologia.

[43]  A. Chakravarty,et al.  Cardiovascular events in systemic lupus erythematosus and rheumatoid arthritis : emerging concepts, early diagnosis and management. , 2007, The Journal of the Association of Physicians of India.

[44]  Y. Le Marchand-Brustel,et al.  Interleukin-1beta-induced insulin resistance in adipocytes through down-regulation of insulin receptor substrate-1 expression. , 2007, Endocrinology.

[45]  M. Prevoo,et al.  Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. , 1995, Arthritis and rheumatism.

[46]  M. Cassader,et al.  Deflazacort vs prednisone. Effect on blood glucose control in insulin-treated diabetics. , 1987, Archives of internal medicine.